Actively Recruiting
European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
Led by Matthias Griese · Updated on 2022-09-21
1000
Participants Needed
3
Research Sites
834 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Generation of a common European database and biobank Continous assessment and implementation of guidelines and treatment protocols Establishment of a large observational cohort of chILD patients Determination the value of outcomes used in child Assess treatment variations used, deliver data from defined protocols and linked outcomes
CONDITIONS
Official Title
European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children with suspected or confirmed interstitial lung disease
- Children with conditions that appear similar to interstitial lung disease
- Children with rare localized lung diseases affecting the lung tissue
You will not qualify if you...
- Presence of any other condition that does not meet the inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Medizinische Hochschule Hannover
Hanover, Lower Saxony, Germany, 30625
Actively Recruiting
2
Hacettepe University, Medical Faculty
Ankara, Sihhiye, Turkey (Türkiye), 06100
Actively Recruiting
3
University of Edinburgh
Edinburgh, United Kingdom, EH4 2XU
Actively Recruiting
Research Team
M
Matthias Griese, Prof.
CONTACT
K
Katarzyna Michel, Dr. med.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here